Chugai presents positive data from Part C of phase I/II NXTAGE study of NXT007 in people switching from emicizumab without a washout period at EAHAD Congress: Tokyo Wednesday, Feb ...
Astellas reaches settlement agreement with Lupin in Myrbetriq patent litigation: Tokyo Wednesday, February 11, 2026, 16:15 Hrs [IST] Astellas Pharma Inc., a global life sciences c ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results